Congressman filed amendment to ensure funds for CBD regulation in appropriations bill, reports NPA

June 18, 2019

The Natural Products Association (NPA; Washington, D.C.) announced today that as a result of its work with congress to encourage FDA to establish a safe use level for dietary supplements and conventional foods containing CBD, Representative Jerry McNerney of California’s 9th congressional district filed an amendment last week to modify the House Agriculture appropriations bill “to include critical funds that would enable FDA to undertake the appropriate processes and set a safe level of CBD for consumers to use each day.”

“With over 1,500 CBD products in the marketplace, consumers have a right to know whether the products they are consuming are safe,” said Daniel Fabricant, PhD, president and CEO of the NPA, in a press release. “This fundamental language would provide companies making and selling CBD products the regulatory clarity they need and consumers the assurance that they deserve that products meet federal safety standards.”

“Since the passage of the 2018 Farm Act – which eliminated hemp from the definition of marijuana under the Controlled Substances Act – we’ve seen a significant increase in the production and sales of CBD products,” added McNerney. “With more and more CBD appearing on supermarket shelves across the country, it’s time for American consumers to have accurate information on CBD and for producers to be properly regulated to make the marketplace safe and reliable.”

The trade group is encouraging members of the industry to contact their Senators and Representatives requesting that they voice support for the inclusion of the amendment in the Appropriations Bills that fund the government. Industry can take further action and tell congress that it wants FDA to exercise enforcement discretion to ensure safe access to CBD products by visiting www.npanational.org/advocacy/natural-products-day/.